Andreas Clemens

Last updated
Andreas Clemens
Dr. Andreas Clemens.jpg
Born (1966-05-05) May 5, 1966 (age 58)
Nationality German
Education University of Göttingen
Kiel University
University Hospital Heidelberg
University of Mainz
University of Freiburg
Occupation(s) Medical Director and Head New Medical Brand Incubator & Rare Disease of Novartis
Medical career
Profession Physician
Institutions Novartis

Andreas Clemens (born May 5, 1966 in Hildesheim) is a German physician. [1] He is an internist, endocrinologist and diabetologist. His main interest is the investigation and development of drugs in the field of cardiology, endocrinology, ophthalmology and very rare diseases.

Life and work

As part of his scientific activities, he has published more than 130 peer-reviewed articles. [2] He has an H-index of 42. [3] He is a member of the European Association for Vision and Eye Research Foundation. [4] He is also an associate editor (editor) at Contemporary Clinical Trials. [5] Furthermore, he is actively involved in teaching at the Albert Ludwigs University of Freiburg, Germany. [6]

Related Research Articles

<span class="mw-page-title-main">Clinical trial</span> Phase of clinical research in medicine

Clinical trials are prospective biomedical or behavioral research studies on human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments and known interventions that warrant further study and comparison. Clinical trials generate data on dosage, safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial—their approval does not mean the therapy is 'safe' or effective, only that the trial may be conducted.

Steve Andreas was an American psychotherapist and author specializing in Neuro-linguistic programming.

<span class="mw-page-title-main">Doug Altman</span> English statistician (1948–2018)

Douglas Graham Altman FMedSci was an English statistician best known for his work on improving the reliability and reporting of medical research and for highly cited papers on statistical methodology. He was professor of statistics in medicine at the University of Oxford, founder and Director of Centre for Statistics in Medicine and Cancer Research UK Medical Statistics Group, and co-founder of the international Equator Network for health research reliability.

<span class="mw-page-title-main">Clemens Fuest</span> German economist (born 1968)

Clemens Fuest is a German economist who has been President of the Ifo Institute for Economic Research and director of the Center for Economic Studies at the University of Munich (LMU) since 2016.

<span class="mw-page-title-main">Pedram Hamrah</span> German-American ophthalmologist

Pedram Hamrah is a German-American ophthalmologist and immunologist. He obtained his M.D. from the University of Cologne, Germany.

Sir John Irving Bell is a Canadian-British immunologist and geneticist. From 2006 to 2011, he was President of the United Kingdom's Academy of Medical Sciences, and since 2002 he has held the Regius Chair of Medicine at the University of Oxford. He was since 2006 Chairman of the Office for Strategic Coordination of Health Research (OSCHR) but in 2020 became a normal member. Bell was selected to the Vaccine Taskforce sometime before 1 July 2020. Bell is also on the board of directors of the SOE quango Genomics England.

<i>Contemporary Clinical Trials</i> Academic journal

Contemporary Clinical Trials is a monthly peer-reviewed medical journal covering clinical trials and research design in clinical medicine. It was established in 2005 and is published by Elsevier. The editor-in-chief is JoAnn E. Manson. it was established in 1980 as Controlled Clinical Trials and obtained its current title in 2005.

<i>Journal for the Study of Antisemitism</i> Academic journal

The Journal for the Study of Antisemitism is a biannual peer-reviewed academic journal published in the United States which covers anthropological, sociological, psychological, legal, historical, philosophical, and political aspects of contemporary antisemitism.

<span class="mw-page-title-main">Stefan H. E. Kaufmann</span> German biologist

Stefan Hugo Ernst Kaufmann is a German immunologist and microbiologist and is one of the highly cited immunologists worldwide for the decade 1990 to 2000. He is amongst the 0.01% most cited scientists of c. 7 million scientists in 22 major scientific fields globally.

The European College of Neuropsychopharmacology (ECNP) is a pan-European, non-profit scientific association that serves as a platform to exchange and promote research in the field of neuropsychopharmacology. The ECNP “is committed to ensuring that advances in the understanding of brain function and human behaviour are translated into better treatments and enhanced public health”. The ECNP organises a number of activities to achieve this aim, such as a yearly congress, workshops, seminars, New Frontiers Meetings, publications, awards, supported talks and much more.

<span class="mw-page-title-main">Patrick Schöffski</span>

Patrick Schöffski is a German medical doctor specializing in internal medicine, hematology and medical oncology.

<span class="mw-page-title-main">Kimball Atwood</span> American medical doctor, researcher and alternative medicine critic

Kimball C. Atwood IV is an American medical doctor and researcher from Newton, Massachusetts. He is retired as an assistant clinical professor at Tufts University School of Medicine and anesthesiologist at Newton-Wellesley Hospital.

Rajendra Achyut Badwe, is an Indian medical doctor and surgical oncologist. He was honoured by the Government of India, in 2013, by bestowing on him the Padma Shri, the fourth highest civilian award, for his contributions to the field of medicine. He is the former Director of Tata Memorial Centre, succeeded by Sudeep Gupta

Kameshwar Prasad is an Indian neurologist, medical researcher, academic. He is an emeritus professor at the All India Institute of Medical Sciences, Delhi (AIIMS), known as a proponent of evidence-based medicine (EBM) and evidence-based healthcare (EBHC). The government of India awarded him the fourth highest civilian honour of the Padma Shri in 1991.

Daljeet Singh Gambhir is an Indian cardiologist, medical academic, researcher and inventor and the Group Director of Cardiology at Kailash Group of Hospitals and Heart Institute, Noida. He is the inventor of Infinnium Paclitaxel-Eluting Stent, a reportedly cheaper drug-eluting stent which he first presented at the EuroPCR meeting held in Paris in 2003. A fellow of the National Academy of Medical Sciences and an honorary fellow of the Indian College of Cardiology, he is reported to have performed over 10,000 coronary interventions. The Government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2016, for his contributions to medicine.

Vasilis Ntziachristos is a Greek American biomedical engineer, scientist, and inventor best known for his development of fundamental and translational research tools for imaging tissues based on fluorescence and optoacoustics.

Joerg Hasford was a German physician, biometrician, and epidemiologist. He had been influential in the study of safety of drugs and pharmacoepidemiology. He was one of the first biostatisticians to look at reliably compiled drug dosing history data in light of pharmacometric consequences. He was the namesake of the Hasford Score, a prognostic score for chronic myeloid leukemia.

Trudie Lang is a Professor of Global Health Research at the University of Oxford. She specialises in clinical trials research capacity building in low-resource setting, and helped to organise the trial for the drug brincidofovir during the 2014 Ebola virus outbreak.

<span class="mw-page-title-main">Noora (vaccine)</span> Vaccine candidate against COVID-19

Noora is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv Sepid Co. in Iran. Introduced in June 2021, it was announced as having "successfully passed the first phase of its clinical trial" two months later.

<span class="mw-page-title-main">Matthias Schwab (pharmacologist)</span> German pharmacologist

Matthias Schwab is a German doctor and university lecturer. He is director of the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology located on the campus of the Robert-Bosch-Hospital in Stuttgart, an institution of the Robert Bosch Stiftung, and holder of the Chair of Clinical Pharmacology at the University of Tübingen as well as Medical Director of the Department of Clinical Pharmacology at the University Hospital Tübingen.

References

  1. Dabigatranetexilat, ein neuer oraler direkter Thrombininhibitor: Klinische Entwicklung. 2014.
  2. "Andreas Clemens - Global Head Medical Affairs Strategy AID & IRD". ResearchGate. Retrieved 3 April 2023.
  3. "Andreas Clemens, MD, PhD".
  4. "EVER ƒ Members - General Assembly".
  5. "Editorial Board - Contemporary Clinical Trials - Journal - Elsevier".
  6. "Vorlesungsverzeichnis anzeigen - Campus Management - HISinOne".